Clinical data indicate higher levels of the proinflammatory cytokines interleukin-6 (IL-6) and interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) in the serum and cerebrospinal fluid of PD patients [6, 7]. This evidence concerns the gene IL6 and Parkinson disease.